Trends in the Utilization of Radiation Therapy (XRT) Among Patients with Non-Hodgkin's Lymphoma (NHL) in the United States (US)

Conclusion: There has been a significant decline in the utilization of XRT among patients with NHL (DLBCL and non-DLBCL) in the US since 2004, likely due to introduction of practice changing systemic therapeutics. There is still significant heterogeneity noted in practice patterns regarding utilization of XRT across the US. Having more standardized guidelines will help streamline delivery of evidence-based patient care.DisclosuresAilawadhi: Celgene: Consultancy; Janssen: Consultancy; Amgen: Consultancy; Takeda: Consultancy; Pharmacyclics: Research Funding.

Source: Blood - November 21, 2018 Category: Hematology Authors: Kumar, V., Sher, T., Vishnu, P., Roy, V., Hazen, A. M., Alegria, V. R., Ailawadhi, M., Ahmed, S., Jani, P., Shareef, Z. T., Bodepudi, S. L., Paulus, A., Chanan-Khan, A. A., Ailawadhi, S. Tags: 902. Health Services Research-Malignant Diseases: Poster III Source Type: research